niacinamide has been researched along with Primary Peritonitis in 10 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In vivo treatment with ip administration of 3-aminobenzamide (10 mg/kg, 1 and 6 hrs after zymosan injection) or nicotinamide (50 mg/kg, 1 and 6 hrs after zymosan injection) significantly decreased mortality, inhibited the development of peritonitis, and reduced peroxynitrite formation." | 3.70 | Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. ( Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosinets, VA | 6 |
| Bagnenko, SF | 1 |
| Mirzabaev, AT | 1 |
| Batotsyrenov, BV | 1 |
| Gorbachev, NB | 1 |
| Miroshnichenko, VN | 1 |
| Batotsyrenova, KhV | 1 |
| Velikiĭ, KF | 1 |
| Gostishchev, VK | 1 |
| Matusevich, EA | 2 |
| Adamenko, GP | 1 |
| Osochuk, SS | 1 |
| Iarotskaia, NN | 2 |
| Cuzzocrea, S | 1 |
| Zingarelli, B | 1 |
| Costantino, G | 1 |
| Sottile, A | 1 |
| Teti, D | 1 |
| Caputi, AP | 1 |
| Nadtoka, VL | 1 |
1 trial available for niacinamide and Primary Peritonitis
| Article | Year |
|---|---|
[Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period].
Topics: Adult; Antioxidants; Drug Combinations; Endotoxemia; Female; Flavin Mononucleotide; Free Radicals; H | 2011 |
9 other studies available for niacinamide and Primary Peritonitis
| Article | Year |
|---|---|
[Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
Topics: Animals; Antioxidants; Drug Combinations; Flavin Mononucleotide; Free Radicals; Inosine Diphosphate; | 2010 |
[Metabolic immunocorrection treatment of experimental widespread purulent peritonitis].
Topics: Animals; Cardiotonic Agents; Cell Movement; Disease Models, Animal; Drug Combinations; Escherichia c | 2012 |
[Correction of protein-lipid composition in liver mitochondria during experimental widespread purulent peritonitis].
Topics: Animals; Cholesterol; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Male; Mitochond | 2012 |
[The immune activity of cytoflavine in the treatment of the diffuse septic peritonitis].
Topics: Adult; Cell Movement; Combined Modality Therapy; Drug Combinations; Female; Flavin Mononucleotide; H | 2012 |
[Metabolic correction of the lipid-transport system in experimental diffuse purulent peritonitis].
Topics: Animals; Biological Transport; Combined Modality Therapy; Drug Combinations; Drug Monitoring; Flavin | 2012 |
[Correction of bioenergetic processes in small intestine during experimental widespread purulent peritonitis].
Topics: Animals; Bacillus; Drug Combinations; Escherichia coli; Flavin Mononucleotide; Injections, Intraperi | 2012 |
[Free-radical oxidation in liver during experimental widespread purulent peritonitis].
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Drug Combinations; Flavin Mononuc | 2012 |
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multip | 1999 |
[The Soviet antibacterial drug chlorophillipt].
Topics: Animals; Anti-Bacterial Agents; Bronchitis; Burns; Carrier State; Depression, Chemical; Drug Resista | 1970 |